25.24 USD
-3.18 (-11.19%)
25.338 USD
+0.1 (+0.39%)
Overall PGNY gets a fundamental rating of 7 out of 10. We evaluated PGNY against 100 industry peers in the Health Care Providers & Services industry. PGNY scores excellent points on both the profitability and health parts. This is a solid base for a good stock. PGNY is growing strongly while it is still valued neutral. This is a good combination! With these ratings, PGNY could be worth investigating further for growth and quality investing!.
1. Profitability
1.1 Basic Checks
- PGNY had positive earnings in the past year.
- In the past year PGNY had a positive cash flow from operations.
- Each year in the past 5 years PGNY has been profitable.
- Each year in the past 5 years PGNY had a positive operating cash flow.
1.2 Ratios
- PGNY has a better Return On Assets (7.11%) than 89.00% of its industry peers.
- PGNY's Return On Equity of 10.10% is fine compared to the rest of the industry. PGNY outperforms 72.00% of its industry peers.
- With an excellent Return On Invested Capital value of 11.24%, PGNY belongs to the best of the industry, outperforming 83.00% of the companies in the same industry.
- PGNY had an Average Return On Invested Capital over the past 3 years of 8.25%. This is in line with the industry average of 9.19%.
- The 3 year average ROIC (8.25%) for PGNY is below the current ROIC(11.24%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.11% | ||
| ROE | 10.1% | ||
| ROIC | 11.24% |
ROA(3y)7.58%
ROA(5y)11.89%
ROE(3y)10.72%
ROE(5y)17.23%
ROIC(3y)8.25%
ROIC(5y)7.66%
1.3 Margins
- PGNY's Profit Margin of 4.46% is fine compared to the rest of the industry. PGNY outperforms 78.00% of its industry peers.
- PGNY's Profit Margin has declined in the last couple of years.
- The Operating Margin of PGNY (6.77%) is better than 70.00% of its industry peers.
- PGNY's Operating Margin has improved in the last couple of years.
- PGNY has a Gross Margin of 22.94%. This is comparable to the rest of the industry: PGNY outperforms 49.00% of its industry peers.
- PGNY's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.77% | ||
| PM (TTM) | 4.46% | ||
| GM | 22.94% |
OM growth 3Y-3.61%
OM growth 5Y1.87%
PM growth 3Y-29.25%
PM growth 5YN/A
GM growth 3Y-1.03%
GM growth 5Y1.85%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), PGNY is creating some value.
- PGNY has less shares outstanding than it did 1 year ago.
- Compared to 5 years ago, PGNY has more shares outstanding
- PGNY has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- PGNY has an Altman-Z score of 8.46. This indicates that PGNY is financially healthy and has little risk of bankruptcy at the moment.
- PGNY's Altman-Z score of 8.46 is amongst the best of the industry. PGNY outperforms 94.00% of its industry peers.
- PGNY has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 8.46 |
ROIC/WACC1.25
WACC8.96%
2.3 Liquidity
- A Current Ratio of 2.96 indicates that PGNY has no problem at all paying its short term obligations.
- PGNY has a better Current ratio (2.96) than 84.00% of its industry peers.
- PGNY has a Quick Ratio of 2.96. This indicates that PGNY is financially healthy and has no problem in meeting its short term obligations.
- PGNY's Quick ratio of 2.96 is amongst the best of the industry. PGNY outperforms 84.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.96 | ||
| Quick Ratio | 2.96 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an nice 8.62% over the past year.
- Measured over the past years, PGNY shows a decrease in Earnings Per Share. The EPS has been decreasing by -4.77% on average per year.
- PGNY shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 11.41%.
- PGNY shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 38.42% yearly.
EPS 1Y (TTM)8.62%
EPS 3Y-4.77%
EPS 5YN/A
EPS Q2Q%36.36%
Revenue 1Y (TTM)11.41%
Revenue growth 3Y32.6%
Revenue growth 5Y38.42%
Sales Q2Q%9.32%
3.2 Future
- Based on estimates for the next years, PGNY will show a very strong growth in Earnings Per Share. The EPS will grow by 32.94% on average per year.
- PGNY is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.83% yearly.
EPS Next Y17.75%
EPS Next 2Y38.5%
EPS Next 3Y32.43%
EPS Next 5Y32.94%
Revenue Next Year11.28%
Revenue Next 2Y10.4%
Revenue Next 3Y10.6%
Revenue Next 5Y8.83%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
- Based on the Price/Earnings ratio of 40.06, the valuation of PGNY can be described as expensive.
- PGNY's Price/Earnings is on the same level as the industry average.
- Compared to an average S&P500 Price/Earnings ratio of 27.30, PGNY is valued a bit more expensive.
- The Price/Forward Earnings ratio is 23.08, which indicates a rather expensive current valuation of PGNY.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of PGNY is on the same level as its industry peers.
- When comparing the Price/Forward Earnings ratio of PGNY to the average of the S&P500 Index (24.04), we can say PGNY is valued inline with the index average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 40.06 | ||
| Fwd PE | 23.08 |
4.2 Price Multiples
- PGNY's Enterprise Value to EBITDA ratio is in line with the industry average.
- Compared to the rest of the industry, the Price/Free Cash Flow ratio of PGNY indicates a rather cheap valuation: PGNY is cheaper than 82.00% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 11.25 | ||
| EV/EBITDA | 17.94 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
- The decent profitability rating of PGNY may justify a higher PE ratio.
- A more expensive valuation may be justified as PGNY's earnings are expected to grow with 32.43% in the coming years.
PEG (NY)2.26
PEG (5Y)N/A
EPS Next 2Y38.5%
EPS Next 3Y32.43%
5. Dividend
5.1 Amount
- PGNY does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
25.24
-3.18 (-11.19%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-06 2025-11-06/amc
Earnings (Next)02-25 2026-02-25/amc
Inst Owners104.67%
Inst Owner Change-0.04%
Ins Owners1.48%
Ins Owner Change0.5%
Market Cap2.18B
Revenue(TTM)1.27B
Net Income(TTM)56.57M
Analysts81.18
Price Target29.68 (17.59%)
Short Float %7.13%
Short Ratio3.53
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.43%
Min EPS beat(2)14.22%
Max EPS beat(2)14.63%
EPS beat(4)3
Avg EPS beat(4)8.02%
Min EPS beat(4)-11.77%
Max EPS beat(4)15%
EPS beat(8)5
Avg EPS beat(8)7.07%
EPS beat(12)9
Avg EPS beat(12)35.08%
EPS beat(16)13
Avg EPS beat(16)94.29%
Revenue beat(2)2
Avg Revenue beat(2)2.31%
Min Revenue beat(2)1.96%
Max Revenue beat(2)2.66%
Revenue beat(4)4
Avg Revenue beat(4)3.39%
Min Revenue beat(4)1.96%
Max Revenue beat(4)5.74%
Revenue beat(8)4
Avg Revenue beat(8)-0.43%
Revenue beat(12)7
Avg Revenue beat(12)0.39%
Revenue beat(16)9
Avg Revenue beat(16)-0.09%
PT rev (1m)-0.04%
PT rev (3m)1.34%
EPS NQ rev (1m)0%
EPS NQ rev (3m)5.45%
EPS NY rev (1m)-14.88%
EPS NY rev (3m)6.34%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.13%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.4%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 40.06 | ||
| Fwd PE | 23.08 | ||
| P/S | 1.72 | ||
| P/FCF | 11.25 | ||
| P/OCF | 10.45 | ||
| P/B | 3.89 | ||
| P/tB | 4.08 | ||
| EV/EBITDA | 17.94 |
EPS(TTM)0.63
EY2.5%
EPS(NY)1.09
Fwd EY4.33%
FCF(TTM)2.24
FCFY8.89%
OCF(TTM)2.41
OCFY9.57%
SpS14.72
BVpS6.5
TBVpS6.19
PEG (NY)2.26
PEG (5Y)N/A
Graham Number9.6
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.11% | ||
| ROE | 10.1% | ||
| ROCE | 14.68% | ||
| ROIC | 11.24% | ||
| ROICexc | 27.43% | ||
| ROICexgc | 30.82% | ||
| OM | 6.77% | ||
| PM (TTM) | 4.46% | ||
| GM | 22.94% | ||
| FCFM | 15.25% |
ROA(3y)7.58%
ROA(5y)11.89%
ROE(3y)10.72%
ROE(5y)17.23%
ROIC(3y)8.25%
ROIC(5y)7.66%
ROICexc(3y)19.18%
ROICexc(5y)17.15%
ROICexgc(3y)20.6%
ROICexgc(5y)18.86%
ROCE(3y)10.79%
ROCE(5y)10.01%
ROICexgc growth 3Y11.16%
ROICexgc growth 5Y-10.91%
ROICexc growth 3Y11.54%
ROICexc growth 5Y-2.19%
OM growth 3Y-3.61%
OM growth 5Y1.87%
PM growth 3Y-29.25%
PM growth 5YN/A
GM growth 3Y-1.03%
GM growth 5Y1.85%
F-Score7
Asset Turnover1.6
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 330.21% | ||
| Cap/Sales | 1.16% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 230.54% | ||
| Profit Quality | 342.01% | ||
| Current Ratio | 2.96 | ||
| Quick Ratio | 2.96 | ||
| Altman-Z | 8.46 |
F-Score7
WACC8.96%
ROIC/WACC1.25
Cap/Depr(3y)177.5%
Cap/Depr(5y)150.16%
Cap/Sales(3y)0.4%
Cap/Sales(5y)0.39%
Profit Quality(3y)290.66%
Profit Quality(5y)196.79%
High Growth Momentum
Growth
EPS 1Y (TTM)8.62%
EPS 3Y-4.77%
EPS 5YN/A
EPS Q2Q%36.36%
EPS Next Y17.75%
EPS Next 2Y38.5%
EPS Next 3Y32.43%
EPS Next 5Y32.94%
Revenue 1Y (TTM)11.41%
Revenue growth 3Y32.6%
Revenue growth 5Y38.42%
Sales Q2Q%9.32%
Revenue Next Year11.28%
Revenue Next 2Y10.4%
Revenue Next 3Y10.6%
Revenue Next 5Y8.83%
EBIT growth 1Y31.12%
EBIT growth 3Y27.82%
EBIT growth 5Y41.01%
EBIT Next Year39.66%
EBIT Next 3Y20.34%
EBIT Next 5Y15.66%
FCF growth 1Y-2.78%
FCF growth 3Y93.67%
FCF growth 5YN/A
OCF growth 1Y2.69%
OCF growth 3Y90.18%
OCF growth 5YN/A
PROGYNY INC / PGNY FAQ
What is the fundamental rating for PGNY stock?
ChartMill assigns a fundamental rating of 7 / 10 to PGNY.
Can you provide the valuation status for PROGYNY INC?
ChartMill assigns a valuation rating of 4 / 10 to PROGYNY INC (PGNY). This can be considered as Fairly Valued.
How profitable is PROGYNY INC (PGNY) stock?
PROGYNY INC (PGNY) has a profitability rating of 7 / 10.
What is the earnings growth outlook for PROGYNY INC?
The Earnings per Share (EPS) of PROGYNY INC (PGNY) is expected to grow by 17.75% in the next year.